PESUB14	Low frequency of activated T cells in people living with HIV, aviremic under treatment, and presenting neurocognitive disorders	Poster exhibition	Neurologic disorders (e.g. CNS malignancies)
EPB124	Low incidence of adverse drug reactions associated with generic-equivalent antiretroviral product substitutions in a publicly-funded HIV treatment program	E-poster	Other ART complications and adverse reactions
EPB158	Low level of virologic failure and resistance in ART-experienced, integrase inhibitor-naïve participants receiving dolutegravir (DTG) and Nucleoside Reverse Transcriptase Inhibitors (NRTIs) combined regimens: 10-year follow-up in the SAILING Study	E-poster	ART in highly treatment-experienced persons
EPE138	'Low PrEP knowledge and high interest among men living with HIV in rural South Africa	E-poster	Innovations and lessons for supporting HIV prevention effective use and treatment adherence
EPC388	Low uptake of exposure-influenced HIV testing among a sample of pre/post-exposure prophylaxis (PrEP/PEP) naïve young men who have sex with men in two U.S. cities: implication for targeted interventions	E-poster	HIV testing to support prevention
EPB026	Low utilization of TB-LAM for TB screening among children under five with advanced HIV disease in Uganda: a descriptive analysis of surveillance data	E-poster	Diagnostics of co-infections and co-morbidities
EPC461	Lower CD4 count in new clients enrolled during Covid-19 pandemic in a global HIV program	E-poster	Effects of the COVID-19 on HIV epidemiology and prevention
EPB094	Lp(a) in people living with HIV	E-poster	Cardiovascular disease
EPA082	Machine learning prediction and phyloanatomic modeling of viral neuroadaptive signatures in the macaque model of human immunodeficiency virus-mediated neuropathology	E-poster	Neuropathogenesis
PEMOE44	Maintaining access to HIV services to persons living with HIV amid the COVID-19 pandemic in Nepal	Poster exhibition	Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era